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        MHC class II (MHC-II) genes encode cell-sur-
face glycoproteins that present antigens to CD4 
T cells to initiate and control adaptive immune 
responses (  1  ). The expression of MHC-II genes 
and accessory genes necessary for antigen pro-
cessing (Ii and HLA-DM) is regulated in a 
developmental fashion in antigen-presenting cells 
and by external signaling through cytokines, 
among which IFN-     is a powerful inducer of 
their expression (  2  ). The transcription factors 
regulatory factor X (RFX), cAMP response ele-
ment binding protein (CREB), and nuclear 
factor  –  Y (NF-Y) bind to proximal promoter 
conserved upstream sequences (termed X1, 
X2, and Y boxes, respectively) of all MHC-II 
genes (for review see references   3  –  5  ), and are 
required and constitutively expressed, but are not 
suffi   cient, to initiate transcription of MHC-II. 
Instead, expression is controlled by the class II 
transactivator (CIITA), a highly regulated tran-
scriptional coactivator that interacts with the 
X-Y box DNA-bound factors (  6, 7  ). At MHC-
II promoters, CIITA serves as an adaptor 
molecule by recruiting several chromatin re-
modeling factors and the general transcription 
machinery (for review see references   3, 8  ). 
Although this paradigm is widely accepted, it is 
not complete. 
  Several lines of evidence suggest that MHC-
II gene expression is controlled by a much more 
complex system. A transgenic mouse developed 
and characterized   >  10 yr ago in which upstream 
sequences of the E     gene were deleted dis-
played aberrant MHC-II expression patterns, 
suggesting that the deleted elements may serve 
a role in tissue-specifi  c expression (  9, 10  ). Anal-
ysis of this region found a distal X-Y box se-
quence. A similarly located X-Y element was 
found upstream of the   HLA-DRA   gene. The 
distal X-Y box region of the   HLA-DRA   gene 
displayed robust acetylation, produced low lev-
els of transcripts, and was suggested to func-
tion as a locus control region (  11  ). Additional 
regions of potential control were also found 
upstream of the   HLA-DRB1   gene (  12  ). A bio-
informatics search of the human MHC-II re-
gion for nonpromoter-associated X and X-Y 
boxes revealed     40 such sequences with vary-
ing degrees of homology (  13  ). Two of these, 
termed X box  –  like region 7 (  XL-7  ) and   XL-8  , 
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  Knockdown of the insulator factor CCCTC binding factor (CTCF), which binds   XL9  , an 
intergenic element located between   HLA-DRB1   and   HLA-DQA1  , was found to diminish 
expression of these genes. The mechanism involved interactions between CTCF and class II 
transactivator (CIITA), the master regulator of major histocompatibility complex class II 
(MHC-II) gene expression, and the formation of long-distance chromatin loops between 
  XL9   and the proximal promoter regions of these MHC-II genes. The interactions were 
inducible and dependent on the activity of CIITA, regulatory factor X, and CTCF. RNA 
fl  uorescence in situ hybridizations show that both genes can be expressed simultaneously 
from the same chromosome. Collectively, the results suggest a model whereby both   HLA-
DRB1   and   HLA-DQA1   loci can interact simultaneously with   XL9  , and describe a new regu-
latory mechanism for these MHC-II genes involving the alteration of the general chromatin 
conformation of the region and their regulation by CTCF. 786 CTCF REGULATES MHC-II EXPRESSION | Majumder et al.
gene (  16  ). This action is responsible for the expression patterns 
associated with the imprinting control region in the mouse 
  H19/Igf2   genes, where CTCF binding and gene expression 
are controlled by methylation of the imprinted region (  17  –  19  ). 
CTCF binding can also prevent the encroachment of hetero-
chromatin to an active gene, and therefore functions as a 
boundary element (  20  ). CTCF binding sites are degenerate 
because of the fact that CTCF can use any number of its 11 
zinc fi  ngers to interact with DNA. The exact mechanisms by 
which CTCF functions in each of these events is not known. 
Although these examples of CTCF biology are extraordinary, 
other potential roles for CTCF are likely. 
  In this paper, the hypothesis that CTCF regulates   HLA-
DRB1   and   HLA-DQA1   expression is tested and the mecha-
nism is explored. Small interfering RNA (siRNA) to CTCF 
was eff  ective at reducing   HLA-DRB1   and   HLA-DQA1   ex-
pression. Coimmunoprecipitation experiments showed that 
CTCF, CIITA, and RFX5 (a subunit of the X1 box factor 
RFX) were in the same complex, suggesting that the CTCF-
bound region (  XL9  ) and the fl  anking   HLA-DRB1   and   HLA-
DQA1   proximal promoters may interact. To determine if 
this was the case, the chromatin conformation capture (3C) 
assay was used to determine if such interactions existed. 
Distinct interactions were observed, suggesting a role for   XL9   
in the regulation of these genes. Interactions with   XL9   were 
dependent on active transcription of MHC-II genes and the 
presence of the MHC-II  –  specifi  c transcription factors CIITA 
and RFX. Moreover,   XL9   interactions were inducible by 
IFN-     in nonimmune cells, supporting a role for   XL9   in 
  HLA-DRB1   and   HLA-DQA1   expression. CTCF was found 
to be required for the interactions, as siRNA-mediated 
positioned between   HLA-DRA   and   HLA-DRB3  , were active 
with respect to their binding of RFX and CIITA and histone 
modifi  cations. These sequences are likely to be remnants of 
the promoters of   HLA-DRB   pseudogenes, but their activity 
suggests that they may serve to increase the accessibility of the 
MHC-II region chromatin in CIITA-expressing cells. 
  Another of these elements,   XL-9  , located in the inter-
genic DNA between   HLA-DRB1   and   HLA-DQA1   (  Fig. 1 A  ), 
was unusual in that it did not appear to bind RFX or 
CIITA but displayed high levels of histone acetylation and a 
histone modifi  cation profi  le that was associated with acces-
sible chromatin (  14  ).   Further investigation of the region 
showed that the acetylation extended for several kilobases in 
both directions from the originally identifi  ed sequence. The 
peak of histone acetylation was located     0.24 kb away from 
the   XL-9   sequence in a region designated   XL9d  .   XL9d   was 
bound by the transcriptional insulator factor CCCTC bind-
ing factor (CTCF). When placed between an SV40 enhancer 
and a promoter,   XL9d  -containing DNA functioned as a 
potent enhancer-blocking element, preventing the expression 
of the reporter gene.   XL9d   was found in nuclear matrix 
preparations, a property associated with CTCF binding re-
gions. These fi  ndings suggested that the   XL-9   region (hence-
forth referred to as   XL9  ) exhibits properties and activities of 
a transcriptional insulator; however, the role of   XL9   and 
CTCF in the expression of the fl  anking MHC-II genes has 
not been elucidated. 
  CTCF is a ubiquitous mammalian transcriptional insulator 
factor with   >  13,000 binding sites in human cells (  15  ). As a 
transcriptional insulator, CTCF binding prevents the actions 
of an enhancer from acting on the promoter of a downstream 
    Figure 1.         CTCF knockdown reduces   HLA-DRB1   and   HLA-DQA1   mRNA levels.   (A) An overall schematic of the   HLA-DRB1   and   HLA-DQA1   gene and   XL9  
region is shown. The conserved proximal promoter elements of the MHC-II genes, W-X-Y, where RFX and CIITA interact are indicated. (B) siRNA to CTCF but 
not an irrelevant siRNA knocked down the expression of CTCF protein. Raji cells were transiently transfected with SMART pool siRNAs to CTCF or GFP and 
assayed by Western blotting for CTCF, RFX5, and     -actin expression at the indicated time points. (C) CTCF siRNA  –  transfected Raji cells displayed a marked 
decrease in   HLA-DRB1   and   HLA-DQA1   mRNA levels as determined by real-time RT-PCR. The decrease in expression of these genes was specifi  c, as a non-
specifi  c siRNA had no effect and   CIITA   and   RFX5   gene expression were not signifi  cantly altered. This analysis was performed three times. The mean of each 
experiment (with SEM) is shown with the data normalized to the levels of   GAPDH .   GAPDH   mRNA levels were unaltered during the course of this analysis.     JEM VOL. 205, April 14, 2008 
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cells that lost CTCF expression also lost surface HLA-DR and 
HLA-DQ but not RFX5 expression (  Fig. 2  ).   siRNA to GFP 
had no eff  ect on HLA-DR or -DQ surface or intracellular 
RFX5 expression. The combined data demonstrate a role for 
CTCF in the expression of these MHC-II genes. 
  CTCF associates with CIITA 
  One way in which CTCF could mediate this eff  ect was if it 
associated with MHC-II transcription factors or a complex 
containing these factors. To determine if this could be the 
case, coimmunoprecipitation experiments were performed to 
test the hypothesis that CIITA and CTCF associate. Immuno-
precipitations using antibodies to CTCF, CIITA, and RFX5 
with lysates from the MHC-II  –  expressing Raji B cells were 
performed (  Fig. 3  ).   In Raji cell lysates, CTCF and CIITA 
were found to associate, as antibodies to each could coprecipi-
tate the other (  Fig. 3, A and B  ). CTCF and CIITA antibodies 
each coprecipitated RFX5, and RFX5 antibodies coprecipi-
tated CTCF (  Fig. 3 B  ). Although CIITA is known to interact 
directly with RFX5 in Raji cells (  24, 25  ), interactions between 
CTCF and RFX5 or CIITA were not previously known. 
Clues to the nature of these interactions were derived from 
CIITA and RFX5 mutant cells. RJ2.2.5 cells were derived di-
rectly from Raji cells by mutagenesis and are MHC-II defi  -
cient because of debilitating deletions in CIITA (  6, 26  –  28  ). 
RJ-CIITA cells are RJ2.2.5 cells that were stably complemented 
knockdown of CTCF expression resulted in the loss of the 
3C product and a reduction in histone modifi  cations associ-
ated with transcription at the promoters of the   HLA-DRB1   
and   HLA-DQA1   genes. RNA fl  uorescence in situ hybridiza-
tion (FISH), used to assess the expression patterns of these 
genes, showed that both   HLA-DRB1   and   HLA-DQA1   
expression could be detected in some cells simultaneously. 
The data describe a novel mechanism for the regulation of 
these immune system genes, a mechanism that may be com-
mon to other MHC-II genes. 
    RESULTS   
  Loss of CTCF results in the reduction of   HLA-DRB1   
and   HLA-DQA1   expression 
  CTCF was found to interact with   XL9   by in vivo (chromatin 
immunoprecipitation [ChIP]) and in vitro (electrophoretic 
mobility shift assay) assays (  14  ) (  15  ). To test the hypothesis that 
CTCF plays a role in the regulation of the fl  anking MHC 
genes   HLA-DRB1   and   HLA-DQA1  , siRNAs were used to 
knockdown the expression of CTCF. The effi   cacy of tran-
siently transfecting SMART pools of CTCF siRNAs into 
Raji cells was tested in the MHC-II  –  expressing Burkitt  ’  s lym-
phoma B cell line Raji. As shown by the knockdown time 
course (  Fig. 1 B  ), CTCF protein was signifi  cantly but not 
completely reduced at 72 h. siRNAs to GFP did not aff  ect 
CTCF protein levels, and     -actin levels were not aff  ected by 
either of the siRNA pools (  Fig. 1 B  ). Similarly, neither the 
control nor CTCF siRNAs altered the expression of the RFX 
subunit factor RFX5 (  Fig. 1 B  ). Assessment of   HLA-DRB1   
and   HLA-DQA1   mRNA expression during the knockdown 
time course assays showed a marked reduction in steady-state 
mRNA levels of both   HLA-DRB1   and   HLA-DQA1   when 
siRNAs to CTCF but not GFP were used (  Fig. 1 C  ). This re-
duction in expression had no eff  ect on the expression of RFX 
and CIITA mRNA (  Fig. 1 C  ), or the expression of   GAPDH  ,   
CARM1  ,   Cox2  ,   cMyc  , or   PRMT1   mRNAs (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20071843/DC1), 
suggesting that a reduction in CTCF expression did not pro-
duce a general inability to express genes transcribed by RNA 
polymerase II. Although CTCF was shown to aff  ect   cMyc   ex-
pression and, consequently, cell growth (  21, 22  ), the lack of 
CTCF control of   cMyc   in Raji cells likely refl  ects the Burkitt 
lymphoma translocation of these cells, whereas   cMyc   is not 
under its normal regulation or chromosome environment (  23  ). 
Additionally, the in vivo occupancy of RFX5 and CIITA 
on the proximal promoters of these genes was unchanged, 
indicating that the ability of MHC-II  –  specifi  c transcription 
factors to bind their regulatory sites was not altered by CTCF 
knockdown (Fig. S2). 
  The presence of CTCF protein and   HLA-DRB1   or   HLA-
DQA1   mRNA after siRNA treatment may have been caused 
by the effi   ciency of the transient transfection of the siRNAs 
into the cells. To examine only those cells that have lost CTCF, 
an intracellular staining fl  ow cytometry assay was developed 
for CTCF and RFX5. When combined with HLA-DR and 
HLA-DQ surface expression staining, the data showed that 
    Figure 2.         CTCF knockdown results in a loss of surface HLA-DR and 
HLA-DQ expression.   Raji cells transiently transfected for 72 h with 
siRNA to CTCF or to GFP as in   Fig. 1   were stained for intracellular CTCF 
and surface MHC-II expression. Two populations of cells exist for the CTCF 
siRNA panels, identifying those cells that were effi  ciently transfected from 
those that were not. GFP siRNA had no effect on the levels of MHC-II or 
CTCF. siRNA-transfected cells were also stained for CTCF, followed by RFX5 
staining. No change in RFX5 levels were observed. The fl  uorophores used 
for detection are indicated (PE and Alexa Fluor 488). Control staining 
patterns for intracellular and surface antibodies are shown. This fi  gure is 
representative of two independent experiments.     788 CTCF REGULATES MHC-II EXPRESSION | Majumder et al.
precipitation reactions. Treatment of lysates with DNase I 
was also performed. Both treatments did not alter the co-
precipitation results (  Fig. 3 C  ), demonstrating that CIITA  –
  CTCF complexes formed independent of DNA. 
  The proximal promoters of   HLA-DRB1   and   HLA-DQA1   
interact directly with   XL9   
  These coimmunoprecipitation results suggest that inter-
actions between   XL9   and the proximal promoters of the   
HLA-DRB1   and   HLA-DQA1   genes may occur. To test this 
hypothesis the 3C assay (  31  –  33  ) was developed for this sys-
tem and used. In the 3C assay, cellular components are cross-
linked with formaldehyde to stabilize in vivo interactions. 
After the isolation of the cross-linked chromatin, the DNA is 
restriction digested, diluted, and ligated under conditions that 
favor intramolecular ligation products. PCR is conducted on 
the purifi  ed DNA to detect whether a novel ligation junction 
is formed between the regions being assayed (  Fig. 4  ).   The 
formation of a novel, specifi  c ligation product signifi  es that 
long-range chromatin interactions occurred in vivo between 
the cis-acting sequences assayed (  31  –  36  ). 
  Thus, to determine if the   HLA-DRB1   and   HLA-DQA1   
proximal promoter regulatory regions interacted with   XL9  , 3C 
assays were performed using Raji cells. A map of the   DR/DQ   
intergenic region with the location of the restriction sites, 
PCR primers, and the predicted novel 3C products is shown 
in   Fig. 4 A  . 3C analysis showed the formation of a novel liga-
tion product between the   Eco  RI restriction fragments encod-
ing   XL9   and the conserved proximal regulatory region of 
  HLA-DRB1  . This   “  3C product  ”   was dependent on formal-
dehyde cross-linking, restriction digestion, and DNA ligation 
(  Fig. 4 B  ). Similarly, a novel ligation product between the 
  HLA-DQA1   W-X-Y  –   and   XL9    –  encoding restriction frag-
ments was detected. The 3C products were cloned, and their 
sequence matched the predicted novel ligation product. No 3C 
products were detected if purifi  ed genomic DNA was used 
(  Fig. 4 B  ), suggesting that the observed products required 
intact chromatin and interactions between the factors bound 
to the respective DNA fragments. The generation of a PCR 
amplicon that was independent of the assay established that 
equal amounts of DNA were present in all reactions and 
  conditions (  Fig. 4 B  , L-7/L-8). To control for nonspecifi  c 
ligation products, 3C was conducted on randomly chosen 
restriction fragments within the intergenic regions between 
  XL9   and each gene. No 3C products were detected (  Fig. 4 B  , 
primers P-1/NC-5 and P-3/NC-6). Several additional con-
trols were conducted (  31  ). PCR amplifi  cation by each primer 
set was tested for effi   cacy on a mix of genomic bacterial artifi  -
cial chromosome (BAC) DNA templates from the   HLA-DR/
DQ   region generated by restriction digestion and religation. 
PCR showed that the primer sets were functional and had 
similar effi   ciencies (Fig. S4, available at http://www.jem.org/
cgi/content/full/jem.20071843/DC1). Additionally, no dif-
ferences in the ability of   Eco  RI to cleave the assayed sites in 
the chromatin preparations were detected in Raji cells or the 
other cell lines examined (unpublished data). 
with a CIITA-expressing vector (  28  ) and express similar 
amounts of CIITA as Raji cells (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20071843/DC1). SJO 
cells, derived from a bare lymphocyte syndrome patient, ex-
press CIITA but lack RFX5, one of the RFX subunits (  29  ). 
Lysates from the mutant cells were examined and showed that 
although CIITA and CTCF associate in the RFX5-defi  cient 
cell line, RFX5-CTCF coimmunoprecipitates were absent in 
the CIITA-defi  cient cell line (  Fig. 3 B  , top). This association 
is restored in the RJ-CIITA  –  complemented cell line (  Fig. 3, 
A and B  ). The lack of CIITA and RFX5 immunoprecipitates 
in RJ2.2.5 and SJO, respectively, demonstrates the specifi  city 
of the antibodies, as does the failure of the nonspecifi  c anti-
body to pull down the factors. Thus, RFX5 and CTCF 
immunoprecipitates are dependent on the presence of CIITA, 
suggesting that the three proteins can associate in a complex. 
It should be noted that these coimmunoprecipitates were ob-
served with endogenously expressed proteins. 
  The possibility that the observed complexes coprecipi-
tated because of the binding of the components to DNA was 
eliminated by including ethidium bromide, an intercalating 
agent that disrupts protein  –  DNA complexes (  30  ), into the 
    Figure 3.         CIITA associates with CTCF.   Cellular lysates from Raji (wild-
type), RJ2.2.5 (CIITA      ,  RFX5 +  ), RJ-CIITA (CIITA  + ,  RFX5 +  ), and SJO (CIITA  + , 
RFX5       ) cells were prepared and immunoprecipitated with the indicated 
antibodies. The immunoprecipitates were analyzed by Western blotting 
for the presence of (A) CIITA, (B, top) CTCF, and (B, bottom) RFX5. CIITA 
was found in immunoprecipitates using CTCF, and CTCF was found in 
coimmunoprecipitates using CIITA and RFX5 antisera in Raji cells, indicat-
ing an association between the factors. The association was not observed 
in RJ2.2.5 cells with either CIITA or RFX5 antisera, suggesting that the 
associations between RFX5 and CTCF were dependent on the presence of 
CIITA. As in earlier papers (references   24, 25  ), RFX5 and CIITA interactions 
were also observed. No interactions with the nonspecifi  c antibody to TCR 
were observed. 10% of the input is indicated (I). (C) Coimmunoprecipita-
tion experiments using either CIITA or TCR antisera in the presence of 
ethidium bromide or treated with DNase I were performed as described 
in Materials and methods. The precipitations were analyzed by immuno-
blotting for RFX5 and CTCF as indicated. Each panel in this fi  gure set is 
representative of at least two independent experiments.     JEM VOL. 205, April 14, 2008 
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interactions occurred during MHC-II transcription and re-
quired the presence of CIITA. Moreover, when the 3C assay 
was conducted on RJ2.2.5 cells that had been stably comple-
mented with CIITA (RJ-CIITA) (  28  ), interactions between 
  XL9   and the regulatory regions of   HLA-DRB1   and   HLA-
DQA1   were restored, demonstrating that CIITA expression 
was required for interactions with   XL9  . 3C interactions 
were not observed in the MHC-II  –  negative, RFX5-defi  cient 
but CIITA-positive SJO cell line (  Fig. 4 B  ), suggesting that 
assembly of the transcription regulatory factors at the   HLA-
DRB1   and   HLA-DQA1   promoters was required for inter-
actions with   XL9  . RFX subunit  –  defi  cient cells do not assemble 
the other RFX subunits (CREB, NF-Y, or CIITA) at their 
X-Y box sequences (  37, 38  ). 
  To determine if   XL9   interacted with other regions be-
tween   HLA-DRB1   and   HLA-DQA1,   real-time PCR primer 
sets spanning the   HLA-DRB1   and   HLA-DQA1   intergenic 
  To demonstrate that the 3C interactions were not specifi  c 
to the model B lymphocyte Raji cell line and occurred in 
primary human B cells, the 3C assay was performed on 
CD19  +   purifi   ed peripheral B cells of healthy volunteers. 
Identical results were observed (  Fig. 4 C  ). Thus, two long-
range chromatin interactions occur between   XL9   and the 
regulatory regions of   HLA-DRB1   and   HLA-DQA1   genes in 
MHC-II  –  expressing B lymphocytes. 
  Interactions with the   XL9   region are dependent on CIITA 
and RFX 
  To ascertain the relationship between MHC-II gene tran-
scription and   XL9  , B lymphocyte cell lines, which are MHC-II 
negative because of mutations in either CIITA or RFX5, 
were used. No 3C PCR product associated with   XL9   and 
the fl  anking MHC-II genes was observed in the CIITA-
defi  cient RJ2.2.5 cells (  Fig. 4 B  ), suggesting that the observed 
    Figure 4.         Long-range chromatin interactions form between   XL9   and the proximal promoter regions of the   HLA-DRB1   and   HLA-DQA1   
genes.   (A) A schematic of the   HLA-DRB1   and   HLA-DQA1   gene region depicts the locations of the   Eco  RI sites (top tick marks) and the primers used (bot-
tom tick marks) in the 3C assays. The position of   XL9   is indicated by a thick purple vertical bar. In the 3C assay, chromatin isolated from formaldehyde  –
  cross-linked cells was digested overnight with a large excess of   Eco  RI. After inactivation of the enzyme, samples were diluted and T4 DNA ligase was 
added. Novel ligation junctions were detected by PCR using the primer sets indicated and 35 cycles of amplifi  cation. 3C PCR primers P-1 with P-2 and P-3 
with P-4 (red) allow detection of the   XL9   restriction fragment with   HLA-DRB1   and   HLA-DQA1  , respectively. (B) Interactions between   XL9   and   HLA-DRB1  
or   HLA-DQA1   are specifi  c and dependent on the presence of CIITA and RFX5. A 3C product was observed in Raji cells when formaldehyde (CH  2 O)  cross-
linking and T4 DNA ligase were included during the assay. Intact chromatin was necessary for the formation of the 3C product, as no product was ob-
served with purifi  ed genomic DNA. 3C product formation required CIITA and RFX5, as no products were observed for RJ2.2.5 or SJO cells, which are 
defi  cient for CIITA and RFX5, respectively. A 3C product was observed in RJ-CIITA cells, which are RJ2.2.5 cells stably complemented with CIITA. PCR assays 
using nonspecifi  c control primers NC-5 (A, green) with P-1 or NC-6 (A, green) with P-3 were used to demonstrate that random ligation of their encoding 
restriction fragments did not occur with   HLA-DRB1   and   HLA-DQA1  , respectively. Loading control primers L-7 and L-8 (blue) amplify DNA contained 
within a single   Eco  RI fragment and serve as a loading control. Fivefold less DNA was added to the PCR reaction for the loading controls. (C) The 3C assay 
was performed on freshly isolated CD19  +   human peripheral B lymphocytes. The experimental conditions were identical to those described in B, with two 
concentrations (50 and 100 ng) of genomic DNA used for the PCR step. gen, genomic DNA.     790 CTCF REGULATES MHC-II EXPRESSION | Majumder et al.
these data (  Figs. 4 and 5  ) demonstrate that long-range chromatin 
interactions form between the 5     proximal regulatory regions 
of the   HLA-DRB1   and   HLA-DQA1   genes and the   XL9   inter-
genic region in a manner that is dependent on the MHC-II  –
  specifi  c transcription factors CIITA and RFX. Importantly, 
these data provide clear genetic proof that the formation and 
detection of 3C products are not random or an artifact of the 
3C assay. 
  IFN-     induces interactions with   XL9   
  To further demonstrate that MHC-II transcription was co-
incident with interactions with the   XL9   region, the 3C assay 
was used on A431 epithelial cells after IFN-     induction of 
MHC-II genes. IFN-     regulates MHC-II expression by con-
trolling the expression of CIITA (  7  ). Thus, if MHC-II tran-
scription and interactions with   XL9   are concurrent events, 
then after IFN-     treatment, MHC-II expression and   XL9   inter-
actions should occur with similar kinetics. A431 cells were 
treated with IFN-     for 0, 6, 12, 18, and 24 h before 3C analysis. 
The mRNA and protein levels for CIITA fi  rst appear at     6 h 
and increase during the time course (  Fig. 6, A and B  ) (  38  ).   
region were designed, tested for amplifi  cation, and used to 
detect 3C products with a series of   XL9   anchor primers 
(  Fig. 5  ).   Test primers and   XL9   anchor primers (Fig. S5, avail-
able at http://www.jem.org/cgi/content/full/jem.20071843/
DC1) were chosen based on relative effi   ciency and the ability 
to produce a single amplicon on   Eco  RI-digested/religated 
BAC DNA encoding the region. Two major peaks were ob-
served with primers 3 and 22 and their   XL9   anchors, which 
denote the   Eco  RI fragments encoding the W-X-Y box re-
gions of   HLA-DRB1   and   HLA-DQA1  , respectively (  Fig. 5 B  ). 
Importantly, the 3C products for these primer sets were 
the only sets that exhibited a signifi  cant reduction in RJ2.2.5 
cells, denoting their relationship to MHC-II expression and 
confi  rming the qualitative data presented in   Fig. 4  . Back-
ground interactions with   Eco  RI fragments close to   HLA-
DRB1   and   HLA-DQA1   can be observed with equal levels 
between Raji and RJ2.2.5 cells. Such 3C background pro-
ducts are seen in other systems (  39  ). Equal amounts of a con-
trol 3C product of the   XL9 Eco  RI fragment ligating to itself 
were observed with an   XL9   anchor primer and primer 15, 
demonstrating that equal preparations were used. Collectively 
    Figure 5.           XL9   interacts with   HLA-DRB1   and   HLA-DQA1  .   To ascertain if   XL9   interacted with other restriction fragments within the   HLA-DRB1 , 
  HLA-DQA1   region, a quantitative 3C assay was used across the region. (A) A schematic showing the subregion and each   Eco  RI site numbered 1  –  23 is shown. 
The orientation of primers specifi  c to these sites is indicated by black arrowheads.   XL9   primers, which served as   “  anchors  ”   for each 3C PCR, are shown by 
a single red arrowhead. Because of the differences in optimal annealing temperature between the restriction fragment primers, multiple   XL9   anchor 
primers were required to produce single PCR products with similar effi  ciencies. Ovals represent the respective W-X-Y box regions. Primers 22 and 24 (blue 
arrowheads) were used to detect interactions between   HLA-DRB1   and   HLA-DQA1  , as described in C. (B) 3C assays were performed on Raji and RJ2.2.5 
cells as in   Fig. 4  . Each 3C assay was compared with its own standard curve generated from the amplifi  cation of an   HLA-DRB1  –   and   HLA-DQA1  – containing 
BAC that had been   Eco  RI digested and ligated. The results from three separate experiments were averaged and normalized against the BAC DNA used in 
the standard curve. The results are plotted with the standard deviation observed. Primer set 15 with its   XL9   anchor serves as a loading control for the 
system, as this ligation product is derived from a single   Eco  RI fragment (  XL9  ). Note that primers 6 and 20 represent the same   Eco  RI fragments as primers 
NC-5 and NC-6 from   Fig. 4  . (C) Raji and RJ2.2.5 cells were used to examine whether the   HLA-DRB1   and   HLA-DQA1   promoter regions interact. A 3C 
product between   HLA-DRB1   (primer 24) and   HLA-DQA1   (primer 22) promoter-containing restriction fragments was detected that was dependent on the 
presence of CIITA. Student  ’  s   t   tests were used to determine the signifi  cance of differences between Raji and RJ2.2.5 samples for each primer set. In B, only 
3C samples using   XL9   anchors with primers 3 and 22 showed signifi  cance (P   <   0.04). The differences in C were found to be signifi   cant  (P   <   0.03).   JEM VOL. 205, April 14, 2008 
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siRNA transient transfection of Raji cells, the   HLA-DRB1/
XL9   and   HLA-DQA1/XL9   3C products were decreased 
substantially but not completely (unpublished data). Incom-
plete loss of the 3C product was likely caused by the siRNA 
transfection effi   ciency, as described in   Fig. 2  . To overcome 
this technical issue, siRNA-transfected cells were separated 
from nontransfected cells by using HLA-DR antibody –  coated 
magnetic beads. The HLA-DR  –  negative cells were assayed 
for formation of the   HLA-DRB1/XL9   and   HLA-DQA1/
XL9   3C products (  Fig. 7 A  ).   A complete loss of the 3C prod-
uct was observed in the CTCF siRNA  –   but not control 
GFP siRNA  –  transfected cells. Control primer amplifi  cations 
(L7/L8) and the intramolecular ligation product (P15/anchor) 
demonstrate equal loading of the samples. In total, these re-
sults suggest that CTCF is required for interactions between 
the proximal promoter regions of   HLA-DRB1   and   HLA-
DQA1   with   XL9  . 
  To ascertain a consequence of CTCF interaction with 
the MHC-II promoters, CTCF and control GFP siRNA 
knockdown cells were assayed by ChIP for histone modi-
fi  cations that are associated with transcriptional activation 
(  Fig. 7 B  ). For the   HLA-DRB1  , a reduction in histone 
H3K9 and K18 acetylation was observed in CTCF but not 
GFP siRNA  –  transfected cells (33 and 45%, respectively). 
Histone H3 K14 acetylation was not aff  ected. A small reduc-
tion in H3 K4 dimethylation (18%) and a modest reduction 
The expression of   HLA-DRB1   and   HLA-DQA1   occurs with 
CIITA mRNA appearance and reaches a maximal level of 
expression in this time course at 24 h. The levels of RFX5 
and GAPDH were unchanged during the treatment (unpub-
lished data). Interactions between   XL9   and   HLA-DRB1   
and   HLA-DQA1   were detected after the 6-h time point 
(  Fig. 6 C  ), a time coincident with high levels of CIITA ex-
pression and, importantly, CIITA assembly at MHC-II pro-
moters (  38  ). MHC-II expression was also observed after 12 h. 
Interactions with   XL9   were maintained during the 24-h time 
course of the assay. These results demonstrated that inter-
actions between   XL9   and the proximal promoters of the 
  HLA-DRB1   and   HLA-DQA1   genes were synchronized with 
active MHC-II expression and were absent in MHC-II  –  neg-
ative cell lines. This inducible system also highlighted the 
specifi  city of the assay by demonstrating that in the absence 
of the inducer (IFN-    ) and in the presence of all other re-
quired elements, no   XL9    –  MHC-II promoter interactions 
were detected. 
  CTCF is required for interactions between   XL9   and   HLA-DRB1   
and   HLA-DQA1   and for maximal histone modifi  cation of the 
promoter regions 
  To test whether CTCF was important for the long-range 
interactions observed, siRNAs to knockdown the expression 
of CTCF were used as described in   Fig. 1  . When assayed after 
    Figure 6.         IFN-     induces long-range interactions between   XL9   and the proximal promoter regions of   HLA-DRB1   and   HLA-DQA1  .   MHC-II –
  negative A431 epithelial cells were treated with IFN-     in a time course that extended to 24 h. (A) mRNA analysis, (B) Western blots, and (C) 3C analysis 
were conducted at the indicated time points. (A) Real-time RT-PCR was performed with   CIITA -,   HLA-DRB1  – ,  and   HLA-DQA1  – specifi  c primers on RNA iso-
lated at the indicated time points after IFN-     treatment. The crossover threshold (Ct) real-time PCR values were normalized to the Ct values of those 
obtained for   GAPDH   mRNA and presented as the mean fold induction with standard error. (B) A Western blot shows that CIITA protein can be detected as 
early as 6 h after IFN-     induction and that the expression of CIITA is maintained over the 24-h time course. (C) The 3C assays were performed on the 
A431 cells as in   Fig. 4  . Interactions between   XL9   and the   HLA-DQA1   and   HLA-DRB1   promoter regions were observed at 12 h after the induction time 
point. All assays were performed at least three times from independently treated cultures.     792 CTCF REGULATES MHC-II EXPRESSION | Majumder et al.
in H3 K4 trimethylation (27%) were observed. At the 
  HLA-DQA1   promoter, more substantial reductions in the 
histone modifi  cations tested were observed in CTCF siRNA  –
  treated cells. GFP siRNA  –  treated cells showed the same 
level of histone modifi  cations as untreated cells (unpub-
lished data). These data suggest that CTCF contributes to 
the modifi  cation of the chromatin structure at the promoters 
of the   HLA-DRB1   and   HLA-DQA1   genes in a manner that 
is favorable to transcription. 
  Expression of HLA-DRB1 and HLA-DQA1 alleles 
  It is generally accepted that all MHC-II genes and alleles are 
coordinately expressed in mature B cells, including Raji cells, 
as determined by surface expression and mRNA levels. Such 
experiments view the steady state of populations or individual 
cells, and thus, it is not known if both alleles are being tran-
scribed simultaneously or whether each locus is active at the 
same time. To determine the allele expression patterns of the 
  HLA-DRB1   and   HLA-DQA1   genes, RNA FISH was per-
formed on Raji and RJ2.2.5 cells using probes for   HLA-
DRB1   and   HLA-DQA1   transcripts (  Fig. 8  ).   A range of 
ex    pression patterns was observed in Raji cells (  Table I  ).   
No RNA FISH signals were observed in the CIITA-defi  -
cient and MHC-II  –  negative RJ2.2.5 cells (unpublished data). 
  HLA-DRB1   was expressed in almost all cells (98.7%). In 77% 
of the cells,   HLA-DRB1   was expressed from both alleles. 
  HLA-DQA1   was expressed in 80% of the cells, but never 
without   HLA-DRB1   expression. In contrast to   HLA-DRB1  , 
only 23% of the cells expressed   HLA-DQA1   from both 
alleles. With 77% of the cells expressing both genes from at 
least one chromosome, these data argue that   HLA-DRB1   and 
  HLA-DQA1   are for the most part expressed at the same time, 
suggesting the possibility that both promoter regions could 
interact with   XL9   simultaneously (  Fig. 8  ). 
  One prediction of these observations is that if the 
  HLA-DRB1   and   HLA-DQA1   promoter regions are being 
expressed at the same time, they may be in close proxim-
ity to each other when associated with   XL9  . This predic-
tion would suggest that a 3C product could be detected 
between the two regions. To ascertain if this was the case, 
3C was performed between the restriction fragments en-
coding the promoters of   HLA-DRB1   and   HLA-DQA1   
(  Fig. 5 C  ). When 3C interactions were compared be-
tween Raji and RJ2.2.5 cells, a 20.6-fold difference was 
observed. The lack of 3C products in RJ2.2.5 cells demon-
strated that CIITA was necessary and that the interaction 
was specific. Although the overall magnitude observed for 
the 3C product in Raji cells in   Fig. 5 C   was not as robust 
as the 3C products formed between the promoter frag-
ments and   XL9   (  Fig. 5 B  ), this was expected because the 
promoter  –  promoter interactions (  Fig. 5 C  ) require two inde-
pendent interaction events to occur, whereas the promoter  –
    XL9   interactions require only a single event. Moreover, 
the RNA FISH data (  Fig. 8   and   Table I  ) indicate that not 
all chromosomes express both   HLA-DRB1   and   HLA-
DQA1   simultaneously. 
    Figure 7.         CTCF is required for interactions between   XL9   and the 
  HLA-DRB1   and   HLA-DQA1   promoter regions.   72 h after CTCF siRNA 
transfection, Raji cells were labeled with anti  –  HLA-DR magnetic beads 
and separated from nontransfected cells by MACS column separation. 
The HLA-DR  –  negative cells were assayed by 3C and compared with 
siRNA GFP  –  transfected cells. Cells were either cross-linked or left un-
treated (control) before 3C. Quantitative 3C primer sets to detect   XL9/
HLA-DRB1   and   XL9/HLA-DQA1  , as indicated in the fi  gure, were used as 
described in   Fig. 5   and Fig. S5. Loading control primer sets from   Fig. 4   
(L-7/L-8) and 3C ligation control primers (15/  XL9   anchor) from   Fig. 5   were 
also used. 3C products were quantitated as in   Fig. 5  . Data from three 
independent chromatin preparations were averaged and plotted with 
their standard deviation. (B) ChIP assays for histone modifi  cations at the 
  HLA-DRB1   and   HLA-DQA1   promoter regions were conducted using the 
indicated antibodies 72 h after cells were transfected with either control 
or CTCF siRNAs. The real-time PCR data were normalized to input and to 
a standard curve for each locus, and the mean of three independent 
assays is shown with standard deviation. Student  ’  s   t   test p-values are 
shown above each comparison.     JEM VOL. 205, April 14, 2008 
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(CTCF) and the proximal regulatory region of the MHC-II 
genes CIITA and RFX. Interactions between CIITA and 
CTCF or complexes containing these factors were observed. 
The results therefore describe a new model for the control of 
MHC-II gene expression and a novel role for CTCF in regu-
lating MHC-II gene activity. 
  The current model predicts that several chromatin orga-
nizational states may exist: inactive, poised, and active. As de-
picted, the active state may occur in MHC-II constitutively 
expressing B lymphocytes and cells induced to express MHC-II 
genes by IFN-    . The active state would feature interactions 
between   XL9   and the promoter regions of the   HLA-DRB1   
and   HLA-DQA1   genes. The data collected using the 3C assay 
represent a population view and not individual haplotypes 
or alleles. Thus, with a recent report suggesting that active 
genes do not continuously transcribe their DNA (  40  ), it was 
possible that only one of the two fl  anking genes was tran-
scribed at a time or interacting with   XL9  . However, the 
RNA FISH data argue that all combinations of expression 
occur, with the predominant combination including   HLA-
DRB1   and   HLA-DQA1   expression from the same chromo-
some. The observation of a CIITA-dependent 3C product 
between the promoter regions of   HLA-DRB1   and   HLA-
DQA1   suggests that both promoter regions are in close prox-
imity when expressed, and supports the model of both 
promoters interacting with   XL9  . Most nonimmune cells are 
CIITA negative and do not express MHC-II genes. In such 
cells, RFX, CREB, and NF-Y are found bound to their X-Y 
    DISCUSSION   
  We demonstrate in this paper that   XL9   forms interactions 
with the promoter regions of the two fl  anking MHC-II 
genes:   HLA-DRB1   and   HLA-DQA1  . These interactions 
span     25 and 15 kb, respectively, and likely form a loop-
type structure connecting the promoter regions of these genes 
to   XL9   (  Fig. 9  ).   The interactions were only observed in cells 
expressing MHC-II gene products constitutively or when in-
duced with IFN-    . Importantly, the interactions were de-
pendent on the presence of factors that interact with   XL9   
    Figure 8.         Transcription of   HLA-DRB1   and   HLA-DQA1   genes.   RNA FISH for   HLA-DRB1   and   HLA-DQA1   mRNA in Raji cells displayed a variety of ex-
pression patterns, suggesting that the neighboring genes could be coexpressed. Three   HLA-DRB1   and   HLA-DQA1   coexpression patterns are shown. The 
complete analysis of all expression patterns is shown in   Table I  . PCR probes corresponding to the middle of each of these genes, including intronic se-
quences, were used. Cells are counterstained with DAPI to highlight the nucleus. No expression was observed in RJ2.2.5 cells (not depicted). Bars, 10   μ  M.     
    Table I.        Expression of MHC-II alleles and genes by RNA FISH 
Alleles expressed Number    a   %
Neither 3 1.3
One DRB1 only 22 9.9
One DQA1 only 0 0
Two DRB1 only 20 9
Two DQA1 only 0 0
One of each: distinct    b   7 3.1
One of each: coincident 18 8.1
Two DRB1 with one DQA1 101 45.3
One DRB1 with two DQA1 2 0.9
Two DRB1 with two DQA1 50 22.4
  a  Based on 223 Raji cells observed from two independent experiments. No signal was 
observed in RJ2.2.5 cells.
  b  Distinct and coincident refer to whether the   HLA-DRB1   and   HLA-DQA1   signals 
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  HLA-DQA1   gene expression; however, the activities never 
approached background levels. This was most likely caused by 
the effi   ciency of transfection of the siRNAs. By intracellular 
staining, cells were either positive or negative for CTCF after 
72 h. CTCF-negative cells did not display MHC-II on their 
surfaces. This suggests that the decreases in CTCF function 
assayed were likely greater than those observed in the quanti-
tative assays in which populations were examined (RNA ex-
pression and histone modifi  cation), and argues that CTCF is 
critical for expression of these genes. Although one might 
predict, because of its binding to     13,000 sites in the human 
genome (  15  ) and the eff  ects of CTCF and cellular activation 
on inducing apoptosis in some B cell lines (  21  ), that CTCF 
knockdown would result in numerous off  -target eff  ects, this 
was not the observed case. CTCF siRNA  –  transfected cells 
proliferated during the time course of assay, implying that a 
large number of genes were expressed, that the cells did not 
enter a quiescent phase, and that the cells did not induce a 
programmed cell death pathway in response to aberrant gene 
expression. This diff  erence from a previous report (  21  ) in 
which CTCF regulates cMyc activity, cell-cycle progression, 
and programmed cell death is likely caused by the Burkitt 
lymphoma translocation in Raji cells that removes   cMyc   from 
its normal regulatory environment (  23  ). Additionally, of the 
box sites, as demonstrated by in vivo genomic footprinting 
and ChIP (  37, 38, 41  ). ChIP analyses also demonstrated that 
the promoter region  –  associated nucleosomes in MHC-II  –
  negative cells still bear accessibility marks, such as histone H3 
lysine 4  2me   (  13  ). Such data suggest that MHC-II genes are 
likely organized in a poised state in cells that lack CIITA and 
do not express MHC-II genes. An inactive state may there-
fore only exist in bare lymphocyte syndrome patient cells that 
are defi  cient in one of the RFX subunits, as cells mutant for 
subunits of the RFX complex display unoccupied MHC-II 
regulatory regions (  37, 41  ). All nucleosome modifi  cations as-
sociated with accessible and active chromatin were near back-
ground levels in RFX-defi  cient cells (  13, 38  ). 
  The model also predicts that RFX and CIITA should be 
detected at   XL9   by ChIP. Although this was not observed 
under the standard conditions in previous experiments (  14  ), 
extending the cross-linking time resulted in moderate detec-
tion of both RFX and CIITA at   XL9   (unpublished data). 
The values were     5  –  20-fold less than the robust binding ob-
served at X-Y box regions. This was expected, as RFX and 
CIITA binding to   XL9   is indirect and would require multiple 
protein  –  protein cross-linking events to detect by ChIP. 
  CTCF siRNA knockdown was found to diminish all as-
sayed activities associated with   XL9   and   HLA-DRB1   and 
    Figure 9.         Models of interactions between   HLA-DRB1   and   HLA-DQA1   and the   XL9   region.   Three potential states are shown. The inactive state 
represents RFX-defi  cient cell types as in SJO cells from bare lymphocyte syndrome patients with no factors bound to the MHC-II proximal regulatory 
regions. In the inactive state, no interactions with   XL9   occur and the proximal regulatory regions of MHC-II genes display background chromatin marks 
associated with the gene activation. A poised state is suggested for normal MHC-II  –  nonexpressing cells. In such cells, RFX  –  CREB  –  NF-Y but not CIITA are 
assembled at the MHC-II proximal regulatory regions. No interactions with   XL9  occur in the poised state, but chromatin marks associated with genes that 
can be activated are present. In MHC-II  –  expressing cells, CIITA is expressed and an   “  active state  ”   is proposed with the proximal promoter regions of the 
  HLA-DRB1   and/or   HLA-DQA1   genes interacting directly with   XL9  . The potential for both genes to interact with   XL9   is depicted, but it is possible that only 
one gene interacts or is transcribed at a time.     JEM VOL. 205, April 14, 2008 
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distinct foci were observed for the diff  erent expressed alleles. 
Microsatellite DNA in the second intron of the HLA-
DRB1*0401 gene was found to bind CTCF in an in vitro 
electrophoretic mobility shift assay (  51  ), suggesting that addi-
tional CTCF sites may exist in the human MHC. Although 
this site was not identifi  ed in a recent ChIP-on-chip analysis 
for CTCF binding in human cells, several other CTCF bind-
ing sites were observed within the MHC-II region (  15  ). It is 
intriguing that these CTCF sites appear between clusters of 
MHC-II genes and, if active, may serve to coordinate the 
expression of the closest MHC-II gene in a manner similar 
to   XL9  . Alternatively, it may be possible that multiple CTCF 
binding sites may contribute to the regulation of the MHC-II 
genes. In either case, the regulation of this gene system may 
depend on having accessible CTCF binding sites to reorga-
nize the chromatin structure, activate, and regulate transcrip-
tion of the MHC-II gene system. 
  MATERIALS AND METHODS 
  Cell culture.     Raji cells, a Burkitt  ’  s lymphoma B cell line that is wild type 
for MHC-II expression, were obtained from the American Type Culture 
Collection. Derived by mutagenesis from Raji cells, RJ2.2.5 cells (provided 
by R. Accolla, University of Insubria, Varese, Italy) are mutant for   CIITA   
(  6, 26  ). RJ-CIITA are RJ2.2.5 cells that have been stably complemented 
with a CIITA expression vector (  28  ). These three cell lines were grown in 
RPMI supplemented with 5% fetal bovine serum, 5% bovine calf serum 
(HyClone, Inc.), 100 U/ml penicillin, 100   μ  g/ml streptomycin, and 0.29 mg/ml 
  l-  glutamine (Invitrogen). SJO cells were derived from a patient with the 
bare lymphocyte syndrome and are defi  cient for MHC-II expression because 
of mutations in their RFX5 genes (  29  ). SJO cells were grown under the de-
scribed conditions except that fetal bovine serum was used at 15%. A431 is 
an epithelial cell line that is negative for MHC-II expression. A431 cells 
were grown in DME with the described supplements and 10% fetal bovine 
serum. For some assays, A431 cells were treated with 500 U/ml IFN-     for 
the time indicated in the fi  gures to induce CIITA and MHC-II expression, 
as previously described (  52  ). 
  Flow cytometry.     Cells were harvested, washed with PBS, and incubated 
with PE-conjugated anti  –  human HLA-DR antibody or unconjugated anti  –
  human HLA-DQ antibody (BD Biosciences). Anti  –  HLA-DQ  –  stained cells 
were incubated with PE-conjugated anti  –  mouse IgG secondary antibody 
(SouthernBiotech). Cells were washed with PBS and fi  xed with 2% parafor-
maldehyde in PBS at room temperature for 10 min, followed by permeabi-
lization with 0.05% saponin in PBS for 30 min. Permeabilized cells were 
incubated in blocking buff  er (1% BSA, 5% normal goat serum, and 0.05% 
saponin in PBS) for 30 min at room temperature. Blocked cells were incu-
bated with anti-CTCF (Chemicon) at 4  °  C overnight, and Alexa Fluor 488 
goat anti  –  rabbit IgG (Invitrogen) was used to detect CTCF. Some CTCF-
stained cells were washed and blocked as described and subsequently stained 
for RFX5 for 1 h using an RFX5 antibody (  53  ) that was conjugated to 
  Alexa Fluor 647 according to the manufacturer  ’  s directions (Invitrogen). 
Control stained samples were processed in parallel using only the secondary 
antibodies indicated in the fi  gures. IgG Alexa Fluor antibodies were pur-
chased from Invitrogen. 
  siRNA treatment.     siRNA treatment was performed to knockdown CTCF 
expression in Raji (wild-type) cells. SMART pool siRNAs (Dharmacon) spe-
cifi  c for CTCF were transfected into 4   ×   10  6   cells using a Nucleofection ap-
paratus and transfection reagents (kit V) from Amaxa Biosystems. siRNA to 
GFP was transfected as a negative control. After transfection, siRNA-treated 
and -untreated cells were harvested at the indicated times. Each of these ex-
periments was performed at least three times with separate transfections. 
10 genes assayed, only the 2 HLA class II genes showed sig-
nifi  cant decreases in expression. This may be because of the 
fact that the aff  ected genes are highly regulated and those not 
aff  ected are likely to be constitutively expressed. This being 
said, we predict that many genes will ultimately be found that 
are regulated by CTCF in these cells. 
  How could   XL9   contribute to the transcription of MHC-
II genes?   XL9   has several activities. Previously, we showed 
that when placed in a reporter assay vector,   XL9   can block 
the activity of the SV40 enhancer with a similar effi   ciency as 
the insulator from the chicken     -globin locus (  14  ). This sug-
gested that in this context   XL9   contains insulator activity. 
As with some other CTCF binding regions (  42  –  44  ),   XL9   asso-
ciates also with the nuclear matrix (  14  ). Here, we found that 
in a CTCF-dependent manner   XL9   participates in the spatial 
reorganization/orientation of the promoters of the neighbor-
ing MHC-II genes when they are expressed through associa-
tion with the MHC-II  –  specifi  c transcription factors. We also 
found that a loss in CTCF activity correlated directly with a 
decrease in some histone modifi  cations, including H3 K9 and 
K18 acetylation, as well as H3 K4  2me  and K4  3me . These marks 
are associated with actively transcribing genes (  45, 46  ) and 
suggest that interactions with   XL9  , which are also dependent 
on the presence of CTCF, function to increase histone acetyl-
transferase recruitment or activity, stabilize the modifi  cations, 
or prevent histone deacetylases from removing the marks at 
the promoters of   HLA-DRB1   and   HLA-DQA1  . These ac-
tivities are consistent with two conclusions. The fi  rst is that 
  XL9   is critical to the activation of the neighboring MHC-II 
genes whereas the second is that its activity is a consequence 
of active transcription. Although the current dataset argue for 
the former, the conclusion is not certain, as experimentation 
involving deletion of the element in human cells is not cur-
rently feasible. 
  In   Drosophila,   insulator elements like   gypsy   are responsible 
for the formation of chromatin loops that organize DNA in 
such a manner that enhancers only aff  ect the genes within 
their own loop and not on adjacent loops (  47  ). In   Drosophila,   
the foci of the loops appear to be organized with respect to 
the nuclear matrix (  47, 48  ). Some of the mechanistic aspects 
of this paradigm may exist here as well with the control of the 
  HLA-DR   and   HLA-DQ   gene expression occurring in sepa-
rate chromatin loops. Although the   HLA-DR   and   HLA-DQ   
genes are considered to be coregulated, they can be found to 
be discordantly regulated in certain non-Hodgkin  ’  s lympho-
mas (  49, 50  ). Aberrant regulation of the   XL9   element may 
allow these regulatory diff  erences to be manifested. 
  In addition to functioning as an insulator at the chicken 
    -globin and mammalian   Igf2/H19   loci, CTCF also functions 
in organizing higher-order chromatin structure. A recent re-
port demonstrated that CTCF binding to the imprinting cen-
ter of the   Igf2/H19   locus enabled direct interactions with 
the   Wsb/NF1   locus, bridging chromosomes 7 and 11 (  19  ). 
Although it is not known whether   XL9   forms additional 
  intra- or interchromosomal interactions, it is unlikely that it 
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formed with antibodies against RFX5 (  53  ), CIITA (  38  ), the histone-specifi  c 
antibodies indicated in the fi  gures (Chemicon), or a TCR antibody (non-
specifi  c control) at 4 °  C overnight. Chromatin –  antibody complexes were incu-
bated with 60   μ  l of protein A  –  sepharose beads in a fi  nal volume of 1 ml for 
another hour and washed eight times and prepared for PCR as previously 
described (  13  ). All ChIP experiments were performed at least three times 
with independent siRNA-treated cell cultures. 
  To determine the amount of DNA associated with ChIP, quantitative 
real-time PCR was performed in a reaction containing SYBR green buff  er 
(5% DMSO, 1  ×   SYBR [BioWhittaker Molecular Applications], 0.04% gela-
tin, 0.3% Tween 20, 50 mM KCl, and 20 mM Tris [pH 8.3]), 3 mM MgCl  2  , 
0.2 mM dNTP, and 100 nM of each primer using an iCycler with an optical 
assembly unit. PCR primers to analyze RFX5 and CIITA occupancy on the 
proximal promoter sequences of   HLA-DRB1   and   HLA-DQA1   genes were 
described previously (  14  ). All of the primer sets used in this study produced 
a single specifi  c amplicon. Quantitation of PCR products was determined 
by comparison to a standard curve produced with each primer set using a 
genomic DNA dilution series consisting of 500, 100, 20, 4, and 0.8 ng. A two-
step PCR with denaturation at 95  °  C for 15 s and annealing and extension at 
62  °  C for 1 min for 45 cycles was conducted. All real-time PCR reactions 
were performed in duplicate. Student  ’  s   t   tests were used to assess signifi  cance 
between samples. 
  Relative quantitative RT-PCR.     Total RNA was isolated using the 
RNeasy mini prep kit (QIAGEN). 2   μ  g RNA was DNase I treated and then 
reverse transcribed in a fi  nal volume of 20  μ  l using Superscript II RT (Invitro-
gen) and buff  ers from an RT-PCR kit (Applied Biosystems) according to 
the manufacturer  ’  s instructions. A negative control reaction lacking reverse 
transcription was performed with each RNA sample. After reverse transcrip-
tion, sample volumes were increased to 200   μ  l with TE buff  er, and 3   μ  l of 
the cDNA produced was used for subsequent quantitative PCR. PCR using 
primers for the   GAPDH   transcripts was conducted in each experiment for 
normalization. Primers used in these assays are listed in Fig. S5. Primers for 
  CIITA   and   GAPDH   were described previously (  38  ). The threshold cycle 
values for all genes were normalized to the threshold cycle values determined 
for   GAPDH  . All real-time RT-PCR assays were repeated at least three 
times from independent RNA preparations. Student  ’  s   t   tests were used to as-
sess signifi  cance diff  erences between samples. 
  Coimmunoprecipitation and Western blotting.     For immunoprecipita-
tion experiments, M-280 sheep anti  –  rabbit and anti  –  mouse magnetic beads 
(Invitrogen) were washed four times with the washing buff  er containing 
0.1% BSA in 1  ×   PBS. 1.5   ×   10  7   beads were incubated overnight with 3   μ  g 
of the appropriate antibody for each immunoprecipitation at 4  °  C. After two 
washes, beads were mixed with 100   μ  g of nuclear extract, which was prepared 
as previously described (  54, 55  ), and the volume was adjusted 300   μ  l by ad-
dition of lysis buff  er (50 mM Tris [pH 8], 150 mM NaCl, and 1% NP-40) 
plus protease inhibitors. Immunoprecipitation reactions were performed for 
3 h at 4  °  C with gentle rotation. Protein-bound beads were washed four 
times with the described lysis buff  er. After the last wash, the beads were re-
suspended in SDS-PAGE sample buff  er. Precipitates were eluted from the 
beads by placement in a boiling bath for 5 min, separated by 6% SDS-PAGE, 
and analyzed by Western blotting. In some experiments, ethidium bromide 
or DNase I were used to determine whether the interactions were indepen-
dent of DNA. 50   μ  g/ml ethidium bromide was added to the nuclear extract 
and incubated on ice for 30 min (  30, 56  ). After incubation, the nuclear ex-
tract was cleared by centrifugation and used for coimmunoprecipitation. For 
DNase I treatment, the coimmunoprecipitation reaction was performed fi  rst 
and was followed by the addition of 30 U/ml DNase I (Roche) and a 5-min 
incubation at room temperature. The protein-bound beads were washed in 
lysis buff  er and examined as described. 
  Western blots were performed according to standard protocols using 
6 or 7.5% SDS-PAGE gels with transfer membranes (Immobilon-P; Milli-
pore). After transfer, membranes were blocked for 1 h at room temperature 
in PBST (PBS, 0.05% Tween 20) and 5% nonfat dry milk. Membranes were 
  3C assay.     3C assays were performed as previously described (  34  ), with some 
modifi  cations. 10  7   cells were resuspended in 50 ml DME supplemented with 
10% fetal bovine serum. Formaldehyde was added to the cells to a fi  nal con-
centration of 1% and incubated at room temperature for 10 min, after which 
the reactions were quenched by the addition of glycine to a fi  nal concentra-
tion of 0.125 M. The cells were lysed using ice-cold lysis buff  er (0.34 M su-
crose, 10 mM Tris, 10 mM NaCl, 1% NP-40) containing protease inhibitors. 
The nuclei were collected from the lysates and washed once with restriction 
enzyme buff  er and resuspended in restriction enzyme buff  er containing 0.1% 
SDS. The samples were incubated on a rotator for 10 min at 37  °  C. Triton 
X-100 was added to a fi  nal concentration of 1%, and the nuclei were incu-
bated for an additional 10 min at 37  °  C to sequester the SDS. The cross-
linked DNA was digested overnight with 1,000 U   Eco  RI.   Eco  RI was heat 
inactivated by incubation at 65  °  C for 20 min. Samples were diluted 1:40 
with ligase buff  er (New England Biolabs, Inc.) and 1% Triton X-100 and 
then incubated for 10 min at 37  °  C. T4 DNA ligase was added, and the sam-
ples were incubated for 4 h at 16  °  C, followed by a 30-min incubation at 
room temperature. 10   μ  g/ml of proteinase K was added to the ligation re-
actions and incubated overnight at 65  °  C to reverse the cross-links and digest 
the proteins. The DNA was extracted with phenol and chloroform and con-
centrated by ethanol precipitation. 50 ng of the precipitated DNA was ana-
lyzed by PCR, with an annealing temperature of 62  °  C for 30 s and 45-s 
extension times at 68  °  C. 35 cycles of PCR were performed. The locations 
of the primer sets used in these assays are shown in   Fig. 4 A  , and their se-
quences are provided in Fig. S5.   HLA-DRB1   and   XL9   3C products were 
detected using primers P-1 and P-2;   HLA-DQA   and   XL9   interactions were 
detected using primers P-4 and P-3. Primers to demonstrate that nonspecifi  c 
interactions were not occurring included NC-5 and NC-6, which were 
used with P-1 and P-3, respectively. Loading controls were derived by PCR 
amplifi  cation of sequences contained within a single restriction fragment us-
ing primers L-7 and L-8. All PCR products were analyzed on 1.5% agarose 
gels stained with ethidium bromide. Each of the PCR products was cloned 
and sequenced to confi  rm its identity. All 3C assays were repeated at least 
three times from independent cultures with identical results. 
  Quantitative 3C assays were performed as described using an XL9 an-
chor primer with each of the 23 primers described in Fig. S5 and real-time 
instrumentation (iCycler; Bio-Rad Laboratories). To derive primer sets that 
would work for all 23 fragments, a total of six XL9 anchor primers (  Fig. 5 A  , 
red arrowhead) were designed and tested with the restriction fragment  – 
specifi  c primers (  Fig. 5 A  , black arrowheads). Primer sequences are provided 
in Fig. S5. All real-time PCR primers were tested on human BAC DNA 
(RP11-257p24) that was   Eco  RI digested and religated to generate all possible 
products. Only primer sets that produced a single amplicon were used. 
To quantitate 3C products, a standard curve was generated for each PCR 
primer/anchor amplicon using a known amount of digested/ligated BAC 
DNA. Data were derived from three independent chromatin samples, aver-
aged, normalized to the relative effi   ciency of amplifi  cation and ligation of the 
BAC DNA, and plotted with their standard deviation. The Student  ’  s   t   test 
comparing Raji and RJ2.2.5 samples was used to assess statistical signifi  cance 
for each 3C primer set. 
  In some experiments, CTCF siRNA  –  transfected cells were separated 
from nontransfected cells based on their loss of HLA-DR surface expression. 
In these experiments, 10  7   cells were transfected with CTCF siRNAs as de-
scribed in the previous section. Cells were washed twice with cold 1  ×   PBS 
and resuspended in 80   μ  l PBE buff  er (1  ×   PBS, 0.5% BSA, and 2mM EDTA). 
20   μ  l of MACS HLA-DR microbeads (Miltenyi Biotec) were added and in-
cubated at 4  °  C for 20 min. Magnetically labeled cells were resuspended 
twice with PBE buff  er and collected by centrifugation at 300   g   for 10 min. 
The separation column was simultaneously prepared by washing with PBE 
buff  er. Cells were applied to the column, and the HLA-DR negative cells 
representing the siRNA-transfected cells were collected and used for the 3C 
assay as described. 
  ChIP assays.     ChIP assays were performed as described previously (  13, 38  ). 
Immunoprecipitations in a 50-  μ  l volume of sonicated chromatin were per-JEM VOL. 205, April 14, 2008 
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incubated with the antibodies indicated in the fi  gures diluted in PBST for 1 h. 
Anti-CTCF and     -actin were purchased from Millipore and Chemicon, 
respectively. After washing in blocking buff  er, horseradish peroxidase  –
  conjugated secondary antibodies were added in PBST containing 5% nonfat 
dry milk for another 1 h. Enhanced chemiluminescence substrate (Renaissance; 
DuPont) was added and the blots were exposed to fi  lm. 
  RNA FISH and immunofl  uorescence.       HLA-DRB1   and   HLA-DQA1   
direct-labeled FISH probes were prepared by nick translation of 1   μ  g of puri-
fi  ed PCR products with either Spectrum orange or green dUTP (Abbott 
Laboratories) at 16  °  C for 2 h. Genomic DNA from Raji cells was amplifi  ed 
using the following PCR primers:   HLA-DRB1  , 5    -GCAGAGAAGCAGA-
CACACAG-3     and 5    -CCATACGGTTTAGGCAAAGGG-3     (located in 
exons 3 and 6); and   HLA-DQA1  , 5    -ATGATTAAACGCTACAACTC-
TACCG-3     and 5    -ATTTCCTTTATCCTAACTTATTTCTCTGTC-3     
(located in exons 2 and 5). Cells were seeded onto poly  –    l  -lysine  –  coated 
microscope slides (Polysciences, Inc.). Approximately 10  6   cells in 1  ×   PBS were 
applied per slide and allowed to settle for 10 min at room temperature. Slides 
were transferred to fi  xative (4% formaldehyde, 0.1% Triton X-100 in 1  ×   
PBS) for 10 min before washing twice for 2 min each in 1  ×   PBS. Slides were 
dehydrated for 3 min each in 70 and 100% ethanol before air drying. Cells 
were washed twice for 2 min in 50% formamide, 2  ×   SSC at room tempera-
ture, followed by two 3-min washes at 37  °  C in 50% formamide, 2  ×   SSC. 
The probes were denatured and hybridized to the slides for 16 h at 37  °  C. 
The slides were washed twice in 50% formamide, 2  ×   SSC at 42  °  C for 8 min 
each, followed by two washes in 2  ×   SSC. The slides were treated in mount-
ing media and counterstained with DAPI (Vector Laboratories). Images 
were collected using Axiovision software (version 4.0) on a microscope 
(Axiovert 200M; both from Carl Zeiss, Inc.). 
  Online supplemental material.     Figs. S1 and S2 extend the CTCF siRNA 
knockdown analysis, showing that the expression of several genes and 
that CIITA and RFX occupancy on MHC-II promoters were not aff  ected 
by CTCF siRNA knockdown, respectively. Fig. S3 showed that the level of 
CIITA protein in the complemented RJ-CIITA cell line was similar to that 
in Raji cells. Fig. S4 displays the amplifi  cation effi   ciencies for the PCR 
amplicons used in the 3C assays from   Fig. 4  . Fig. S5 provides a table of primers 
used in this study. Online supplemental material is available at http://www
.jem.org/cgi/content/full/jem.20071843/DC1. 
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